Genetic causes of early-onset cone and cone-rod vision loss

Genetics of early onset retinal diseases

NIH-funded research University of California-Irvine · NIH-11327951

This project uses advanced genome sequencing and lab testing to find genetic causes of early-onset cone and cone-rod vision loss in patients and their families.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California-Irvine NIH-funded
Lab location1 site (Irvine, United States)
Project IDNIH-11327951 on NIH RePORTER

What this research studies

We will study people and families with early-onset cone and cone-rod inherited retinal disease, focusing on the more than 570 families whose genetic cause is still unknown. The team will use both short- and long-read whole genome sequencing to find mutations that standard tests miss and then perform lab-based functional tests to see how candidate changes damage cone photoreceptors. The work builds on a collection of over 1,500 well-characterized families and combines human genetic data, biological models, and existing clinical information. The goal is to increase the number of patients who receive a clear genetic diagnosis and to clarify the biological mechanisms behind cone degeneration.

Who could benefit from this research

Good fit: People with early-onset cone dystrophy, cone-rod dystrophy, or Leber congenital amaurosis—especially those whose prior genetic testing did not find a cause—are the ideal candidates.

Not a fit: Patients with adult-onset, primarily rod-driven retinal disease, non-genetic vision loss, or an already-known causative mutation may not receive direct benefit from this project.

Why it matters

Potential benefit: If successful, this work could let more patients get a precise genetic diagnosis, improve counseling, and expand eligibility for gene-specific therapies or clinical trials.

How similar studies have performed: Similar genome-sequencing plus functional validation approaches have already found new genes for inherited retinal diseases, though use of long-read sequencing specifically for unsolved cone disorders is a more recent advance.

Where this research is happening

Irvine, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Candidate Disease Gene
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.